Vol 2004, No 50 (2004)

Table of Contents

Research & Development

Merix and Kirin Collaborate on Dendritic Cell Vaccine Development Abstract pdf
Business Review Editor
Alnylam and Merck Sign Second RNAi Agreement in 10 Months Abstract pdf
Business Review Editor

Licensing

Vernalis Licenses its Lead Compound for Parkinson’s disease to Biogen Idec Abstract pdf
Business Review Editor
CuraGen Licenses Seattle Genetics’ ADC Technology Abstract pdf
Business Review Editor

General

Vertex: An Accomplished Dealmaker Abstract
Business Review Editor

Company Profile

Oxford BioMedica plc Abstract pdf
Business Review Editor

Distribution & Marketing

Millennium Grants GSK European Marking Rights to Integrilin® Abstract pdf
Business Review Editor

Business Commentaries

Europe's Need to Nurture Biotech html
Fintan Walton

Deal Trackers

Plenaxis (abarelix) Abstract pdf
Business Review Editor

Mergers & Acquisitions

Chromos to Acquire CellExSys and its T-Cell Technology Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.